1. Home
  2. ALEX vs EVO Comparison

ALEX vs EVO Comparison

Compare ALEX & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALEX
  • EVO
  • Stock Information
  • Founded
  • ALEX 1870
  • EVO 1993
  • Country
  • ALEX United States
  • EVO Germany
  • Employees
  • ALEX N/A
  • EVO N/A
  • Industry
  • ALEX Real Estate Investment Trusts
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALEX Real Estate
  • EVO Health Care
  • Exchange
  • ALEX Nasdaq
  • EVO Nasdaq
  • Market Cap
  • ALEX 1.2B
  • EVO 1.4B
  • IPO Year
  • ALEX N/A
  • EVO 2021
  • Fundamental
  • Price
  • ALEX $15.79
  • EVO $3.32
  • Analyst Decision
  • ALEX Buy
  • EVO Strong Buy
  • Analyst Count
  • ALEX 2
  • EVO 1
  • Target Price
  • ALEX $24.00
  • EVO $7.00
  • AVG Volume (30 Days)
  • ALEX 431.8K
  • EVO 54.6K
  • Earning Date
  • ALEX 10-30-2025
  • EVO 11-05-2025
  • Dividend Yield
  • ALEX 5.75%
  • EVO N/A
  • EPS Growth
  • ALEX 65.09
  • EVO N/A
  • EPS
  • ALEX 1.01
  • EVO N/A
  • Revenue
  • ALEX $226,062,000.00
  • EVO $887,395,283.00
  • Revenue This Year
  • ALEX N/A
  • EVO N/A
  • Revenue Next Year
  • ALEX $2.00
  • EVO $10.78
  • P/E Ratio
  • ALEX $15.56
  • EVO N/A
  • Revenue Growth
  • ALEX N/A
  • EVO N/A
  • 52 Week Low
  • ALEX $15.51
  • EVO $2.84
  • 52 Week High
  • ALEX $19.97
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • ALEX 29.52
  • EVO 28.51
  • Support Level
  • ALEX $15.52
  • EVO $3.30
  • Resistance Level
  • ALEX $17.07
  • EVO $4.09
  • Average True Range (ATR)
  • ALEX 0.28
  • EVO 0.09
  • MACD
  • ALEX -0.07
  • EVO -0.08
  • Stochastic Oscillator
  • ALEX 15.65
  • EVO 1.55

About ALEX Alexander & Baldwin Inc. REIT Holding Company

Alexander & Baldwin Inc is a Hawaii commercial real estate company. The group owns, operates, and manages million square feet of retail, industrial, and office space in Hawaii. It is a real estate investment trust (REIT) and the owner of grocery and drug-anchored retail centers in the state. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces, and also urban ground leases in Hawaii, thereby accounting for a majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: